OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
July 02, 2012
A Q&A with Thomas E. D'Ambra, Chairman, CEO, & President of AMRI, on recent industry trends.
Taking time to appreciate the industry's greatest achievements will inspire growth ahead.
Companies roll out expansions in manufacturing high-potency APIs and finished products.
Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.
Presidents of leading associations offer views on the industry's future.
June 02, 2012
Industry wants more innovation, but can suppliers meet customer needs?
Highlights included the latest in pharmaceutical packaging equipment, containers, and labels and new capabilities among contract service providers.
May 02, 2012
Clinical research organizations see reform in clinical-trial process, including the establishment of chief innovation officer at FDA.
Recovery audits and other past practices in procurement can improve the bottom line.
Apple's experience with manufacturing facilities in China present opportunity for future best practice.